![Russell Clayton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Russell Clayton
Hoofd Techniek/Wetenschap/O&O bij
LARIMAR THERAPEUTICS, INC.
Vermogen: 217 901 $ op 30-06-2026
Profiel
Russell G.
Clayton is currently Chief Medical Officer at Larimar Therapeutics, Inc. since 2023.
Former positions include Regional Medical Director-Scientific Affairs at Merck & Co., Inc., Director-Asthma Program Division at The Children's Hospital of Philadelphia Foundation, Chief Medical Officer at Alcresta Therapeutics, Inc. from 2015 to 2017, and Senior Vice President-Research & Development at Windtree Therapeutics, Inc. from 2011 to 2014.
Education includes undergraduate studies at LaSalle University and a doctorate from Philadelphia College of Osteopathic Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 26-01-2026 | 71.443 ( 0,08% ) | 217 901 $ | 30-06-2026 |
Actieve functies van Russell Clayton
| Bedrijven | Functie | Begin |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 17-07-2023 |
Eerdere bekende functies van Russell Clayton
| Bedrijven | Functie | Einde |
|---|---|---|
Alcresta Therapeutics, Inc.
 Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops enzyme-based products that deliver enzymatic solutions to those living with rare diseases | Hoofd Techniek/Wetenschap/O&O | 01-04-2017 |
| WINDTREE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-2014 |
The Children's Hospital of Philadelphia Foundation
 The Children's Hospital of Philadelphia Foundation Hospital/Nursing ManagementHealth Services Provides health care services | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Russell Clayton
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
41
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Windtree Therapeutics, Inc.
 Windtree Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics to address significant unmet medical needs in acute care markets | Health Technology |
LaSalle University
 LaSalle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Children's Hospital of Philadelphia Foundation
The Children's Hospital of Philadelphia Foundation Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Philadelphia College of Osteopathic Medicine
 Philadelphia College of Osteopathic Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops enzyme-based products that deliver enzymatic solutions to those living with rare diseases | Health Technology |
Larimar Therapeutics, Inc.
 Larimar Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing treatments for complex rare diseases | Health Technology |
